Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval
RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management,…
RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management,…
The gene therapy market is predicted to experience rapid growth over the coming years. But with that growth will come many complexities…
Lung cancer is the leading cause of cancer deaths globally. Non-small cell lung cancer, which originates from larger cells such…
The uptake of decentralized clinical trials (DCTs) solutions was greatly accelerated by the COVID-19 pandemic, with lockdowns necessitating that research…
Cystic fibrosis (CF) is a genetic disorder caused by mutations in the CFTR gene, affecting chloride and bicarbonate transport in…
WCG Clinical reports that failure rates for clinical trials involving the central nervous system (CNS) exceed 85% during Phases II…
Impacting approximately 1 in 5,000 males globally, Duchenne Muscular Dystrophy is a rare genetic disorder characterised by progressive muscle weakness…
ROVI: Building the foundation for expansion into Europe For ROVI, a specialty biopharma company headquartered in Spain with ambitious growth…
Finding the right contract development and manufacturing organisation (CDMO) isn’t easy. In a crowded pharmaceutical market, CDMOs must offer specialist…
"Cardiovascular disease is preventable in many cases and early identification of risk is essential, especially for people at high risk," emphasizes…